NYSE:WST - West Pharmaceutical Services Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $103.67 -3.14 (-2.94 %) (As of 03/22/2019 04:00 PM ET)Previous Close$106.81Today's Range$103.52 - $106.6352-Week Range$82.74 - $125.09Volume168,433 shsAverage Volume416,534 shsMarket Capitalization$7.69 billionP/E Ratio36.89Dividend Yield0.57%Beta1.25 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company has a development agreement with scPharmaceuticals Inc. for the development of FUROSCIX, a treatment of edema in patients with heart failure. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. Receive WST News and Ratings via Email Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Fabricated rubber products, not elsewhere classified Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNYSE:WST Previous Symbol CUSIP95530610 CIK105770 Webwww.westpharma.com Phone610-594-2900Debt Debt-to-Equity Ratio0.14 Current Ratio3.15 Quick Ratio2.40Price-To-Earnings Trailing P/E Ratio36.89 Forward P/E Ratio36.38 P/E Growth3.33 Sales & Book Value Annual Sales$1.72 billion Price / Sales4.48 Cash Flow$4.2108 per share Price / Cash Flow24.62 Book Value$18.85 per share Price / Book5.50Profitability EPS (Most Recent Fiscal Year)$2.81 Net Income$206.90 million Net Margins12.05% Return on Equity15.89% Return on Assets11.05%Miscellaneous Employees7,700 Outstanding Shares74,190,000Market Cap$7.69 billion Next Earnings Date4/25/2019 (Estimated) OptionableOptionable West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions What is West Pharmaceutical Services' stock symbol? West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST." How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services? West Pharmaceutical Services declared a quarterly dividend on Friday, February 22nd. Stockholders of record on Wednesday, April 17th will be paid a dividend of $0.15 per share on Wednesday, May 1st. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.58%. The ex-dividend date is Tuesday, April 16th. View West Pharmaceutical Services' Dividend History. How will West Pharmaceutical Services' stock buyback program work? West Pharmaceutical Services announced that its board has initiated a share repurchase program on Thursday, February 15th 2018, which allows the company to repurchase 800,000 shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's leadership believes its shares are undervalued. How were West Pharmaceutical Services' earnings last quarter? West Pharmaceutical Services Inc. (NYSE:WST) announced its quarterly earnings data on Thursday, February, 14th. The medical instruments supplier reported $0.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.01. The medical instruments supplier had revenue of $422.50 million for the quarter, compared to analysts' expectations of $432.38 million. West Pharmaceutical Services had a net margin of 12.05% and a return on equity of 15.89%. West Pharmaceutical Services's revenue was up 1.7% compared to the same quarter last year. During the same period last year, the firm earned $0.64 earnings per share. View West Pharmaceutical Services' Earnings History. When is West Pharmaceutical Services' next earnings date? West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for West Pharmaceutical Services. What guidance has West Pharmaceutical Services issued on next quarter's earnings? West Pharmaceutical Services issued an update on its FY19 earnings guidance on Thursday, February, 14th. The company provided EPS guidance of $2.77-2.89 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.12. The company issued revenue guidance of $1.795-1.820 billion, compared to the consensus revenue estimate of $1.84 billion.West Pharmaceutical Services also updated its FY 2019 guidance to $2.77-2.89 EPS. What price target have analysts set for WST? 1 brokers have issued 12-month price objectives for West Pharmaceutical Services' shares. Their forecasts range from $85.00 to $85.00. On average, they expect West Pharmaceutical Services' stock price to reach $85.00 in the next twelve months. This suggests that the stock has a possible downside of 18.0%. View Analyst Price Targets for West Pharmaceutical Services. What is the consensus analysts' recommendation for West Pharmaceutical Services? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for West Pharmaceutical Services. Has West Pharmaceutical Services been receiving favorable news coverage? Media headlines about WST stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. West Pharmaceutical Services earned a news sentiment score of 2.2 on InfoTrie's scale. They also gave news headlines about the medical instruments supplier a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. Who are some of West Pharmaceutical Services' key competitors? Some companies that are related to West Pharmaceutical Services include ASTELLAS PHARMA/ADR (ALPMY), Actelion (ALIOF), Alexion Pharmaceuticals (ALXN), FRESENIUS SE &/S (FSNUY), Zimmer Biomet (ZBH), ESSILOR INTL S/S (ESLOY), Centene (CNC), Fresenius Medical Care AG & Co. (FMS), Eisai (ESALY), TERUMO CORP/ADR (TRUMY), McKesson (MCK), Align Technology (ALGN), LONZA GRP AG/ADR (LZAGY), COLOPLAST A/S/ADR (CLPBY) and Fresenius Medical Care AG & Co. KGaA (FME). What other stocks do shareholders of West Pharmaceutical Services own? Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Johnson & Johnson (JNJ), Walmart (WMT), Alibaba Group (BABA), Veeva Systems (VEEV), Biogen (BIIB), Pfizer (PFE) and Micron Technology (MU). Who are West Pharmaceutical Services' key executives? West Pharmaceutical Services' management team includes the folowing people: Mr. Eric M. Green, CEO, Pres & Director (Age 49)Mr. David A. Montecalvo, Sr. VP of Global Operations & Supply Chain (Age 54)Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)Mr. William J. Federici, Advisor (Age 59) Who are West Pharmaceutical Services' major shareholders? West Pharmaceutical Services' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.37%), Oregon Public Employees Retirement Fund (3.83%), WCM Investment Management LLC (1.50%), Fisher Asset Management LLC (1.25%), 1832 Asset Management L.P. (1.19%) and Bank of New York Mellon Corp (1.10%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services. Which institutional investors are selling West Pharmaceutical Services stock? WST stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Victory Capital Management Inc., Bank of New York Mellon Corp, Bank of America Corp DE, Eaton Vance Management, Retirement Systems of Alabama, Riverbridge Partners LLC and Mawer Investment Management Ltd.. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone, Karen Flynn and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services. Which institutional investors are buying West Pharmaceutical Services stock? WST stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Norges Bank, BlackRock Inc., First Trust Advisors LP, Millennium Management LLC, Massachusetts Financial Services Co. MA, Lord Abbett & CO. LLC and Geode Capital Management LLC. View Insider Buying and Selling for West Pharmaceutical Services. How do I buy shares of West Pharmaceutical Services? Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is West Pharmaceutical Services' stock price today? One share of WST stock can currently be purchased for approximately $103.66. How big of a company is West Pharmaceutical Services? West Pharmaceutical Services has a market capitalization of $7.69 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe. What is West Pharmaceutical Services' official website? The official website for West Pharmaceutical Services is http://www.westpharma.com. How can I contact West Pharmaceutical Services? West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected] MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)Community Ranking: 1.9 out of 5 ()Outperform Votes: 181 (Vote Outperform)Underperform Votes: 298 (Vote Underperform)Total Votes: 479MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: What are the benefits of a balanced fund?